Table 5 Testing scheme by randomization group. The UCP-LF antibody assay will be performed at the designated laboratory on all the samples collected at T0 from the women attending the visit at both intervention and control training centres. The maternal Hb will be measured at the CSB from all the women in all the sites attending T0, T1, T3 and T4 visits. The UCP-CF CAA and the UCP-LF CAA assays will be performed at the designated laboratory on all the samples collected at T0 from all the women in all the sites and at T3 from all the children in all the sites. The POC-CCA test will be performed for all the women attending the T0, T3 and T4 visits and for all the children attending T3 and T4 visits at the CSB belonging to the intervention group. The POC-CCA test will be also performed at the designated laboratory on all the samples collected at T0 from all the women in all the sites and at T3 from all the women and children in all the sites. PCR will be performed at the designated laboratory on all the samples collected at T0 from the women attending the visit at both intervention and control training centres. Microscopy will be performed at the designated laboratory on all the samples collected at T0 from the women attending the visit at the intervention training centre (one of the two non-randomised centres)
